4.7 Article

Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study

Francesco Alessandri et al.

Summary: This study analyzed the incidence of bloodstream infections (BSI) due to Candida in COVID-19 patients supported with ECMO, and found that the incidence of candidemia was significantly higher in the ECMO group compared to the control group. This result was confirmed by survival analysis and multivariable analyses.

JOURNAL OF FUNGI (2023)

Review Virology

Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis

Shanchen Wei et al.

Summary: This systematic review and meta-analysis assessed the ability of procalcitonin (PCT) as a potential marker for coinfections in patients with COVID-19. The results showed that PCT has limited sensitivity and specificity in predicting coinfections, but lower PCT levels seem to indicate a decreased probability of having a coinfection.

VIROLOGY JOURNAL (2023)

Article Respiratory System

Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19

Avi J. J. Cohen et al.

Summary: The study evaluated the usefulness of procalcitonin as an immune biomarker for diagnosing bacterial superinfection in severe COVID-19 patients. However, the results showed that procalcitonin measurement was not effective in distinguishing bacterial infection.

EUROPEAN CLINICAL RESPIRATORY JOURNAL (2023)

Article Multidisciplinary Sciences

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

Natalie J. Atallah et al.

Summary: This study evaluates whether procalcitonin (PCT) can predict clinical outcome and bacterial superinfection in patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The results suggest that baseline PCT levels are associated with outcome and bacterial superinfection in patients hospitalized with SARS-CoV-2.

PLOS ONE (2022)

Article Public, Environmental & Occupational Health

Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil

Matheus Polly et al.

Summary: The study found that during the COVID-19 pandemic, the overall incidence density of multidrug-resistant infections increased, with significant increases in CRAB and MRSA infections in ICU settings. Meanwhile, there was a decrease in CRE and CRP infections. Infection control teams should be vigilant about possible outbreaks of CRAB and MRSA and promote adherence to infection control measures as healthcare needs evolve during and after the pandemic.

AMERICAN JOURNAL OF INFECTION CONTROL (2022)

Article Anesthesiology

A retrospective comparison of COVID-19 and seasonal influenza mortality and outcomes in the ICUs of a French university hospital

Donatien de Marignan et al.

Summary: This study evaluated the mortality and burden of COVID-19 and seasonal influenza pneumonia in ICUs in Lyon, France. The study found that despite COVID-19 patients being younger and having fewer comorbidities compared to influenza patients, the risk of death associated with COVID-19 was higher. The severity of illness and treatment requirements were also higher for COVID-19 patients.

EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2022)

Review Microbiology

The Prevalence and Impact of Coinfection and Superinfection on the Severity and Outcome of COVID-19 Infection: An Updated Literature Review

Samya A. Omoush et al.

Summary: Patients with COVID-19 are at higher risk of secondary infections, including bacterial coinfections. However, studies have yielded contradictory results regarding the impact of coinfection on the outcomes of COVID-19. This literature review aims to provide updated evidence on the prevalence, mechanisms, and impact of coinfection and superinfection among patients with SARS-CoV-2.

PATHOGENS (2022)

Article Critical Care Medicine

Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients

Nandini Patel et al.

Summary: The study found that procalcitonin (PCT) has limited utility in predicting secondary bacterial pneumonia in critically ill patients with severe COVID-19 pneumonia, as well as in predicting disease severity or mortality outcomes.

JOURNAL OF INTENSIVE CARE MEDICINE (2022)

Article Medicine, General & Internal

Incidence of Bacterial and Fungal Secondary Infections in COVID-19 Patients Admitted to the ICU

Afnan J. Alshrefy et al.

Summary: Secondary bacterial and fungal infections are common among COVID-19 patients admitted to the ICU, with a predominance of gram-negative bacteria and Candida species. The development of secondary infections is significantly associated with invasive mechanical ventilation. Poor clinical outcomes have been observed, including prolonged hospital and ICU stays and higher mortality.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)

Review Infectious Diseases

Clinical Utility of Procalcitonin on Antibiotic Stewardship: A Narrative Review

Jong Hun Kim

Summary: Procalcitonin (PCT) is a useful marker for bacterial infection, and clinical studies have shown that it can guide antibiotic treatment by stratified levels, leading to a reduction in antibiotic usage without adverse outcomes. It has been approved for guiding antibiotic treatment in sepsis and lower respiratory tract infections in the United States and Korea.

INFECTION AND CHEMOTHERAPY (2022)

Article Infectious Diseases

Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study)

Marco Falcone et al.

Summary: This study described the clinical characteristics and outcomes of COVID-19 patients who developed secondary infections due to carbapenem-resistant Enterobacterales (CRE). The results showed that most infections occurred in the ICU, and HAP/VAP was the strongest predictor of death, with a 30-day mortality rate of 33.3%.

JAC-ANTIMICROBIAL RESISTANCE (2022)

Article Infectious Diseases

Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)

Cristina Mussini et al.

Summary: This study summarized the literature on the management of COVID-19 to assist frontline healthcare workers in better understanding the current evidence for disease treatment and guidelines. The research team conducted a detailed review of literature and clinical trial results to develop treatment indications for different COVID-19 patients.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Letter Medicine, General & Internal

Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit

Charlotte Vanhomwegen et al.

IRISH JOURNAL OF MEDICAL SCIENCE (2021)

Article Microbiology

Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019

Michael May et al.

Summary: The role of procalcitonin in identifying community-associated bacterial infections among patients with coronavirus disease 2019 is not yet established. Procalcitonin did not reliably identify bacterial coinfections, but may be useful in excluding bacterial infection.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Editorial Material Medicine, General & Internal

Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic

Alessandro Russo et al.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Critical Care Medicine

Ability of procalcitonin to distinguish between bacterial and nonbacterial infection in severe acute exacerbation of chronic obstructive pulmonary syndrome in the ICU

Cedric Daubin et al.

Summary: Procalcitonin levels showed limited accuracy in predicting bacterial infection in severe AECOPD patients, despite higher levels in those with bacterial infection. PCT may not be reliable as a standalone marker for initiating antibiotic treatment in this population.

ANNALS OF INTENSIVE CARE (2021)

Article Critical Care Medicine

Hospital-Acquired Infections in Critically Ill Patients With COVID-19

Giacomo Grasselli et al.

Summary: Critically ill patients with COVID-19 are at high risk for hospital-acquired infections (HAIs), especially ventilator-associated pneumonia (VAP) and bloodstream infections (BSIs) caused by multidrug-resistant organisms. HAIs prolong mechanical ventilation and hospitalization, and those complicated by septic shock nearly double mortality rate.
Article Infectious Diseases

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19

Isabell Pink et al.

Summary: The study retrospectively analyzed patients admitted with COVID-19 between March 6th and October 30th, 2020. It found that PCT and CRP levels may be helpful in differentiating secondary bacterial infections in patients with COVID-19.ROC analysis showed that PCT and CRP had high efficacy in identifying secondary bacterial infections, with specific cut-off values for optimal sensitivity and specificity.

INFECTION (2021)

Article Medical Laboratory Technology

Elevated procalcitonin concentrations in severe Covid-19 may not reflect bacterial co-infection

Randeep S. Heer et al.

Summary: Elevated procalcitonin concentrations in COVID-19 patients are associated with respiratory failure, prolonged invasive mechanical ventilation, and inpatient mortality, which may be independent of bacterial co-infection.

ANNALS OF CLINICAL BIOCHEMISTRY (2021)

Article Medical Laboratory Technology

Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients

Alberto Dolci et al.

Summary: Although PCT testing can be used as a predictor of bacterial co-infection and patient death, it did not provide significant added value in COVID-19 patients compared to other more common laboratory tests. Its major application lies in its ability to exclude bacterial co-infection with a high negative predictive value when a specific cut-off is applied.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medicine, General & Internal

Bloodstream infections in critically ill patients with COVID-19

Daniele Roberto Giacobbe et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Medicine, General & Internal

Monocyte activation in systemic Covid-19 infection: Assay and rationale

Fernando O. Martinez et al.

EBIOMEDICINE (2020)

Article Medical Laboratory Technology

Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use

Philipp Schuetz et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

Editorial Material Critical Care Medicine

ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units

Diamantis Plachouras et al.

INTENSIVE CARE MEDICINE (2018)

Article Immunology

Role of Procalcitonin in the Management of Infected Patients in the Intensive Care Unit

David N. Gilbert

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Microbiology

Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections

Kevin B. Laupland et al.

CLINICAL MICROBIOLOGY REVIEWS (2014)

Review Medical Laboratory Technology

Update on Procalcitonin Measurements

Michael Meisner

ANNALS OF LABORATORY MEDICINE (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Methods for Calculating Sensitivity and Specificity of Clustered Data: A Tutorial

Tessa S. S. Genders et al.

RADIOLOGY (2012)

Article Critical Care Medicine

Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro

MWN Nijsten et al.

CRITICAL CARE MEDICINE (2000)

Article Critical Care Medicine

The natural elimination rate of procalcitonin in patients with normal and impaired renal function

M Meisner et al.

INTENSIVE CARE MEDICINE (2000)